Mankind Pharma Limited — Cyborg Score 7/10

Strong
Pharmaceuticals & Biotechnology

Strategic Profile

The company holds the #1 rank in prescriptions over the last 8 years. Several of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Beyond pharmaceuticals, the company engages in trading and exporting of healthcare products, manufacture of packing materials and ayurvedic products, and offers products under 20+ recognized brand names.

Cyborg Score Rationale

Q3 FY26 revenue grew 11.5% YoY to ₹3,567 Cr with adjusted EBITDA margin of 25.9%, reflecting solid operational performance. The company benefits from market leadership in prescriptions and strong consumer healthcare brands, though recent regulatory scrutiny warrants monitoring.

Top Insights

  • Market leader with #1 ranking in prescription growth for 8+ consecutive years
  • Strong consumer healthcare portfolio with multiple #1 category brands (Manforce, Prega News, Unwanted-72)
  • Solid revenue growth of 11.5% YoY in Q3 FY26 with 25.9% EBITDA margins demonstrating operational efficiency
  • GST department conducted search at linked facility in February 2026; operations remained unaffected during inspection

Named Competitors

  • Sun Pharma — Large Indian pharma with diversified therapeutic portfolio
  • Cipla — Major Indian pharmaceutical manufacturer with broad product range
  • Gland Pharma — Emerging Indian pharma competitor
  • Divi's Laboratories — Leading Indian pharmaceutical company

Recent Developments

  • (Feb 2026) Board meeting scheduled for Feb 3 to approve Q3 and 9-month financial results
  • (Feb 2026) GST Department conducted search and seizure at Bharat Serums (linked to Mankind); operations continued normally
  • (Jan 2026) Stock surged 3.5% intraday to Rs 2,320.4 outperforming broader market indices
  • (Jan 2026) Company scheduled to participate in investor conferences (Systematix MANTHAN, Axis Capital Advantage India) in Mumbai

Open the full interactive Mankind Pharma Limited report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →